Tennessee HB 2457: TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.

Status: Taken off notice for cal in s/c Tenncare Subcommittee of Insurance Committee (as of 2026-03-03)

State: Tennessee · Session: 114 · Bill: HB 2457

Subjects: TennCare

Sponsors: Harris

View Tennessee HB 2457 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.